Evidence map›Paper›PMID 41764107›Full record

ArticleMikrochimica acta2026

One nanozyme, three functions: substrate-switchable Cu-NH₂-BDC nanozyme for multiplexed biosensing in physiological environments.

Zhiyuan Luo, Yuwan Lu, Ya Wang, Runrun Yang, Yixin Liu, Guobin Xiong, Lingyun Cheng, Hailong Shi, Yaling Yuan, Siqi Li

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhiyuan LuoSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, PR China.
Yuwan LuSchool of Chemistry and Chemical Engineering, Chongqing University of Science and Technology, Chongqing, 401331, PR China.
Ya WangSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, PR China.
Runrun YangSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, PR China.
Yixin LiuSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, PR China.
Guobin XiongSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, PR China.
Lingyun ChengSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, PR China.
Hailong ShiSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, PR China.
Yaling YuanDepartment of Clinical Laboratory, Affiliated Central Hospital of Chongqing University of Technology, The Seventh People's Hospital of Chongqing, Chongqing, 400054, PR China.
Siqi LiSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, PR China. lisiqi47@cqut.edu.cn.

Funding

China Postdoctoral Science Foundation 2023M740428High Quality Development Plan for Graduate Education Foundation of Chongqing University of Technology CYS240723Science and Technology Research Program of Chongqing Municipal Education Commission KJZD-K202401106the National Natural Science Foundation of China 22206018
6 · The paper itself

Abstract

An amino-functionalized copper-based metal–organic framework (Cu–NH₂–BDC) is reported that integrates intrinsic fluorescence with versatile catalytic functions, including oxidase (OXD), peroxidase (POD), and laccase (LAC) activities. Engineering amino group and the central metal node enables Cu–NH₂–BDC to overcome the intrinsic pH limitations of most nanozymes, achieving its highest catalytic efficiency at physiological pH (7.4). Remarkably, Cu–NH₂–BDC exhibits substrate-switchable catalytic behavior, in which the substrate itself directs the dominant enzymatic pathway. This unique mechanism allows precise regulation of substrate-specific catalytic signaling while minimizing interference among multiple catalytic modes. Leveraging these properties, we established a triple-mode biosensing platform capable of highly sensitive and selective detection of acetylcholinesterase (AChE; LOD = 0.001 mU/mL), dopamine (DA; LOD = 0.048 µg/mL), and ascorbic acid (AA; LOD = 0.6 µM) under physiological conditions. This work introduces a novel substrate-engineering strategy for modulating multi-colorimetric signal in nanozymes and provides a powerful and generalizable approach for developing intelligent multifunctional biosensors.

Indexed as

AcetylcholinesteraseAscorbic AcidBiosensing TechniquesCopperDopamineMetal-Organic FrameworksCatalysisColorimetryLaccaseLimit of DetectionPeroxidaseAcetylcholinesteraseAscorbic AcidCopperDopamineLaccaseMetal-Organic FrameworksPeroxidaseBiosensingMetal-organic frameworkMulti-enzyme activitiesRatiometric fluorescenceSubstrate modulation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.